Wenjian Gan
- Molecular Biology top 5%
- Cancer-related gene regulation 12
- Epigenetics and DNA Methylation 10
- PI3K/AKT/mTOR signaling in cancer 8
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 7
- DNA Repair Mechanisms 5
- RNA modifications and cancer 5
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Cell Biology top 5%
- Aging top 10%
- Oncology top 10%
- Journals
- Nature (1 paper)Science (1 paper)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Wenjian Gan
33 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.7k
- Cancer Research 317
- Cell Biology 227
- Aging 23
- Oncology 325
Countries citing papers authored by Wenjian Gan
This map shows the geographic impact of Wenjian Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjian Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjian Gan more than expected).
Fields of papers citing papers by Wenjian Gan
This network shows the impact of papers produced by Wenjian Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjian Gan. The network helps show where Wenjian Gan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjian Gan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 20 | |
| 8 | 2019 | 61 | |
| 9 | 2019 | 47 | |
| 10 | 2019 | 114 | |
| 11 | 2017 | 37 | |
| 12 | 2016 | 89 | |
| 13 | 2016 | 42 | |
| 14 | 2015 | 307 | |
| 15 | SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression | 2015 | 1 |
| 16 | 2015 | 11 | |
| 17 | 2015 | 63 | |
| 18 | 2015 | 153 | |
| 19 | 2012 | 27 | |
| 20 | 2011 | 348 |
About Wenjian Gan
Wenjian Gan is a scholar working on Molecular Biology, Cancer Research and Cell Biology, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related gene regulation (12 papers), Epigenetics and DNA Methylation (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (7 papers), DNA Repair Mechanisms (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Cancer Research (317 citations) and Cell Biology (227 citations). Wenjian Gan has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Wenyi Wei, Pengda Liu, Jianping Guo, Jinfang Zhang, Xialu Li, James L. Manley, Ting Gui, Jie Liu, Alex Toker and Shasha Yin. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.